Last update :
08/05/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Vasodilator   Phentolamine mesylate  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Ora Verse Canada, United States of America
Phentolamine mesylate France
Regitine Netherlands
Stability of mixtures   Injection   Stability of mixtures : Phentolamine mesylate     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass None 0,5 mg/ml
Injection   Phentolamine mesylate   
Injection   Papaverine hydrochloride 30 mg/ml
25°C
30 Day
Not specified 456
Level of evidence A
Glass None 0,5 mg/ml
Injection   Phentolamine mesylate   
Injection   Papaverine hydrochloride 30 mg/ml
5°C
30 Day
Protect from light 456
Level of evidence A
Glass NaCl 0,9% + antibacterial 0,125 mg/ml
Injection   Phentolamine mesylate   
Injection   Alprostadil 12,5 µg/ml
Injection   Papaverine hydrochloride 4,5 mg/ml
-20°C
180 Day
Protect from light 1899
Level of evidence A
Glass NaCl 0,9% + antibacterial 0,125 mg/ml
Injection   Phentolamine mesylate   
Injection   Alprostadil 12,5 µg/ml
Injection   Papaverine hydrochloride 4,5 mg/ml
4°C
30 Day
Protect from light 1899
Level of evidence A
Polypropylene NaCl 0,9% or Glucose 5% 0,037 mg/ml
Injection   Phentolamine mesylate   
Injection   Doxofylline 0,74 mg/ml
20-25°C
24 Hour
Light 3172
Level of evidence A+
  Mentions Légales